Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer
NCT ID: NCT00410618
Last Updated: 2018-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
42 participants
OBSERVATIONAL
2003-04-30
2006-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is looking at the neurological effects of chemotherapy and radiation therapy in patients with colon cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Changes in Adult Cancer Survivors
NCT01569932
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
NCT02767388
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
NCT02290834
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI
NCT03137095
Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy
NCT01506440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* Identify the nature and long-term ramifications of CNS injury as a result of cancer treatment in patients with colon cancer.
Secondary
* Analyze differences in cognitive measures and MRI data in these patients.
* Correlate MRI measures with cognitive performance in these patients.
OUTLINE: Patients undergo cognitive performance assessment and MRI.
PROJECTED ACCRUAL: A total of 42 patients will be accrued for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cognitive assessment
magnetic resonance imaging
management of therapy complications
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of colon cancer
* Received chemotherapy and radiotherapy for colon cancer
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Arizona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sheryl Reminger, MD
Role: STUDY_CHAIR
University of Arizona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.